Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

Nature Medicine

Volumn 2, Issue 7, 1996, Pages 767-775

  Lehner, Thomas ^a   Wang, Yufei ^a   Cranage, Martin ^b   Bergmeier, Lesley A ^a   Mitchell, Elaine ^a   Tao, Louisa ^a   Hall, Graham ^b   Dennis, Mike ^b   Cook, Nicola ^b   Brookes, Roger ^a   Klavinskis, Linda ^a   Jones, Ian ^c   Doyle, Carl ^c   Ward, Robert ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c NATURAL ENVIRONMENT RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACACA; NONHUMAN; PRIORITY JOURNAL; RECTUM MUCOSA; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA MUCOSA; VIRUS ENVELOPE;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY-PRODUCING CELLS; B-LYMPHOCYTES; CHEMOKINES; FLUORESCENT DYES; ILEUM; INTESTINAL MUCOSA; LYMPH NODES; MACACA MULATTA; MALE; SAIDS VACCINES; SIMIAN IMMUNODEFICIENCY VIRUS; SUPPRESSOR FACTORS, IMMUNOLOGIC; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 15844394511     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0796-767     Document Type: Article

References (49)

1. Mayer, K.H. et al. Association of human T lymphotrophic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy. Am. J. Med. 80, 357-363 (1987).
2. Piot, P. & Laga, M. Genital ulcers, other sexually transmitted diseases, and the sexual transmission of HIV. Br. Med. J. 298, 623-624 (1989).
3. World Health Organization. AIDS 4 Global data. Weekly Epidemiol. Rec. 70, 5-12 (1995).
4. Hussain, L. & Lehner, T. Comparative investigation of Langerhans cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 85, 475-484 (1995).
5. Ho, D.D., Schooley, R.T., Rota, T.R., Kaplan, J.C. & Flynn, T. HTLV-III in the semen and blood of a healthy homosexual man. Science 226, 451-453 (1984).
6. Mathijs, J.M. et al. HIV infection of rectal mucosa. Lancet i, 1111 (1988).
7. Adachi, A. et al. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J. Virol. 61, 209-213 (1987).
8. Bourinbaiar, A.S. & Phillips, D.M. Transmission of human immunodeficiency virus from monocytes to epithelia. J. Acquir. Immune Defic. Syndr. 4, 56-63 (1991).
9. Hussain, L.A. et al. The expression of Fc receptors for immunoglobulin G in human rectal epithelium. AIDS 5, 1089-1094 (1991).
10. Amerongen, H.M. et al. Transepithelial transport of HIV-1 by intestinal M cells: A mechanism for transmission of AIDS. J. Acquir. Immune Defic. Syndr. 4, 760-765 (1991).
11. Yahi, N., Baghdiguian, S., Moreau, H. & Fantini, J. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J. Virol. 66, 2848-4854 (1992).
12. Furuta, Y. et al. Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 91, 12559-12563 (1994).
13. Hussain, L., Kelly, C.G., Rodin, A., Jourdan, M. & Lehner, T. Investigation of the complement receptor 3 (CD11b/CD18) in human rectal epithelium. Clin. Exp. Immunol. 102, 384-388 (1996).
14. Cranage, M.P. et al. Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus. Lancet 339, 273-274 (1992).
15. Clerici, M. et al. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 8, 1391-1395 (1994).
16. Pauza, C.D. et al. Pathogenesis of SIVmac51 after atraumatic inoculation of the rectal mucosa in rhesus monkeys. J. Med. Primatol. 22, 154-161 (1993).
17. Stott, E.J. Anti-cell antibody in macaques. Nature 353, 393 (1991).
18. Arthur, L.O. et al. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258, 1935-1938 (1992).
19. Lehner, T. et al. T- and B-cell functions and epitope expression in non-human primates immunized with SIV by the rectal route. Proc. Natl. Acad. Sci. USA 90, 8638-8642 (1993).
20. Walker, B.D. et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328, 345-348 (1987).
21. Nixon, D.F. et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336, 484-487 (1988).
22. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234, 1563-1566 (1986).
23. + cell anti-HIV activity: Nonlytic suppression of virus replication. AIDS Res. Hum. Retrovir. 8, 1039-1050 (1992).
24. + T cells. Science 270, 1811-1815 (1995).
25. Baier, M., Werner, A., Bannert, N., Metzner, K. & Kurth, R. HIV suppression by interleukin-16. Nature 378, 563 (1995).
26. Paxton, W.A. et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med. 2, 412-417 (1996).
27. Pantaleo, G. et al. HIV infection is active and progressive in lymphoid tissue during clinically latent stage of disease. Nature 362, 355-358 (1993).
28. Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122 (1995).
29. Ho, D.D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126 (1995).
30. Lehner, T. et al. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal and urinary immune responses in non-human primates. J. Immunol. 153, 1858-1868 (1994).
31. Rud, E.W. et al. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J. Gen. Virol. 75, 529-543 (1994).
32. Rose, J. Silvera, P., Flanagan, B., Kitchin, P. & Almond, N. The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo. J. Virol. Methods 51, 229-239 (1995).
33. Horan, P.K. & Slezak S.E. Stable cell membrane labelling. Nature 340, 167-168 (1989).
34. Beavis, A.J. & Pennline, K.J. Tracking of murine spleen cells in vivo: Detection of PKH26-labeled cells in the pancreas of non-obese diabetic (NOD) mice. J. Immunol. Methods 170, 57-65 (1994).
35. Moore, M.W., Carbone, F.R. & Bevan, M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54, 777-785 (1988).
36. Klavinskis, L. et al. Induction of cytotoxic T-lymphocytes by mucosal or associated lymphoid tissue immunization of macaques with a recombinant SIV p27 vaccine. Clin. Immunol. Immunopathol. 76, Abs. 476, pS82 (1995).
37. Ashworth, L.A.E. et al. Constitutive expression of major histocompatibility complex class II antigens on monocytes and B cells correlates with disease in simian immunodeficiency virus-infected rhesus macaques. J. Infect. Dis. 172, 1261-1267 (1995).
38. Lehner, T. et al. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258, 1365-1369 (1992).
39. Miller, C.J., Alexander, N.J., Vogel, P., Anderson, J. & Marx, P.A. Mechanism of genital transmission of SIV: A hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J. Med. Primatol. 21, 64-68 (1992).
40. Thapar, M.A., Parr, E.L. & Parr, M.B. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology 70, 121-125 (1990).
41. Mackewicz, C.E., Yang, L.C., Lifson, J.D. & Levy, J.A. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet 344, 1671-1673 (1994).
42. Mazanec, M.B., Kaetzel, C.S., Lamm, M.E., Fletcher, D. & Nedrud, J.G. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA 89, 6901-6905 (1992).
43. Bergmeier, L.A. et al. Characterization of antigen specific B cells in the peripheral blood and tissues after immunization with SIV proteins and challenge with live virus. Clin. Immunol. Immunopathol. 76, Abs. 627, pS107 (1995).
44. Spira, A.I. et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183, 215-225 (1996).
45. Zinkernagel, R.M. Immunology taught by viruses. Science 271, 173-178 (1996).
46. Doyle, C.B., Bhattacharyya, U., Kent, K.A., Stott, J.E. & Jones, I.M. Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus. J. Virol. 69, 1256-1260 (1995).
47. Czerkinsky, C., Russell, M.W., Lycke, N., Lindblad, M. & Holmgren, J. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun. 57, 1072-1077 (1989).
48. Eriksson, K. et al. Amplified ELISPOT assay for the detection of HIV-specific antibody-secreting cells in subhuman primates. J. Immun. Methods 153, 107-113 (1992).
49. Mackewicz, C.E., Ortega, H. & Levy, J.A. Effect of cytokines on HIV replication in CD4+ lymphocytes: Lack of identity with the CD8+ cell antiviral factor. Cell Immunol. 153, 329-343 (1994).